-
1مورد إلكتروني
عناروين إضافية: ВОСТОЧНАЯ И ЗАПАДНАЯ МОДЕЛИ СОЦИОКУЛЬТУРНОГО И ГОСУДАРСТВЕННОГО МЕНЕДЖМЕНТА: ПЕРСПЕКТИВЫ КОНВЕРГЕНЦИИ
СХІДНА І ЗАХІДНА МОДЕЛІ СОЦІОКУЛЬТУРНОГО ТА ДЕРЖАВНОГО МЕНЕДЖМЕНТУ: ПЕРСПЕКТИВИ КОНВЕРГЕНЦІЇالمصدر: Bulletin of Kyiv National University of Culture and Arts. Series in Management of Social and Cultural Activity; Том 2, № 1 (2019); 64-81; Вестник Киевского национального университета культуры и искусств. Серия: Менеджмент социокультурной деятельности; Вісник Київського національного університету культури і мистецтв. Серія: Менеджмент соціокультурної діяльності; 2617-1104; 2616-7573
مصطلحات الفهرس: management, civilization, culture, East-West dichotomy, personality, society, government, 005:[316.7+321](5:[4+7]), менеджмент, цивилизация, культура, дихотомия «Восток-Запад», личность, общество, государство, менеджмент, цивілізація, культура, дихотомія «Схід-Захід», особистість, суспільство, держава, УДК 005:[316.7+321](5:[4+7]), info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion
-
2مورد إلكتروني
مصطلحات الفهرس: 4 acetamido 3 (pentan 3 yloxy) 5 [(4 phenoxybenzyl)amino]cyclohex 1 ene 1 carboxylic acid, 4 acetamido 3 (pentan 3 yloxy) 5 [[4 (pentan 3 yloxy)benzyl]amino]cyclohex 1 ene 1 carboxylic acid, 4 acetamido 3 (pentan 3 yloxy) 5 [[4 (phenylsulfonyl)benzyl]amino]cyclohex 1 ene 1 carboxylic acid, 4 acetamido 3 (pentan 3 yloxy) 5 [[4 (phenylthio)benzyl]amino]cyclohex 1 ene 1 carboxylic acid, 4 acetamido 3 (pentan 3 yloxy) 5 [[4 (thiophen 2 yl thio)benzyl]amino]cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 amino 3 (1 ethylpropoxy) 1 cyclohexene 1 carboxylic acid, 4 acetamido 5 [(4 benzoylbenzyl)amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [(4 benzylbenzyl)amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [(4 ethylbenzyl)amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [(4 isopropylbenzyl)amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [(4 methoxybenzyl)amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [[3 (cyclopentyl)benzyl]amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [[3 (sec butylthio)benzyl]amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [[4 (benzo[b]thiophen 2 yl)benzyl)amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [[4 (cyclohexylthio)benzyl]amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [[4 (cyclopentyl)benzyl]amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [[4 (isobutylthio)benzyl]amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, 4 acetamido 5 [[4 (sec butylthio)benzyl]amino] 3 (pentan 3 yloxy)cyclohex 1 ene 1 carboxylic acid, antivirus agent, diclofenac, ethyl 4 acetamido 3 (pentan 3 yloxy) 5 [[4 (phenylthio)benzyl]amino]cyclohex 1 ene 1 carboxylate, ethyl 4 acetamido 5 [[4 (benzo[b]thiophen 5 yl)benzyl]amino] 3 (pentan 3 yloxy) cyclohex 1 ene 1 carboxylate, oseltamivir, oseltamivir derivative, propafenone, ribavirin, testosterone, unclassified drug, unindexed drug, virus sialidase, zanamivir, animal experiment, animal model, antiviral activity, area under the curve, Article, bioassay, controlled study, drug clearance, drug half life, drug potency, drug stability, drug structure, drug synthesis, human, human cell, Influenza A virus, Influenza A virus (H3N2), Influenza A virus (H5N1), Influenza A virus (H5N2), Influenza A virus (H5N6), Influenza A virus (H5N8), maximum concentration, MDCK cell line, metabolic stability, molecular model, nonhuman, pharmacokinetic parameters, plasma concentration-time curve, rat, time to maximum plasma concentration, Basic Medicine, Medicinska och farmaceutiska grundvetenskaper, Article in journal, info:eu-repo/semantics/article, text
URL:
http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-247045Test
Journal of Medicinal Chemistry, 0022-2623, 2018, 61:22, s. 9976-9999 -
3مورد إلكتروني
المصدر: Bioorganic & Medicinal Chemistry : the tetrahedron journal for research at the interface of chemistry and biology, Vol. 21, no. 6, p. 1451-1464 (2013)
مصطلحات الفهرس: Aryl sulfonamide inhibitors, 1 (4 aminosulfonylphenyl) 3 hydroxyethyl 5 phenyl 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (1 naphthyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (2 methoxyphenyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (2 naphthyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (2 phenantryl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (3 methoxyphenyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (4 bromophenyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (4 methoxyphenyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (4 tolyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (5 bromo 6 methoxynaphtalen 2 yl) 1h pyrazole, Breast cancer, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 (6 methoxynaphtalen 2 yl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 phenyl 1h pyrazole, 1 (4 aminosulfonylphenyl) 3 hydroxymethyl 5 pyridinyl 1h pyrazole, 1 (4 aminosulfonylphenyl) 4 hydroxymethyl 5 (2 naphthyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 4 hydroxymethyl 5 (6 methoxy 2 naphtalenyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 4 hydroxymethyl 5 phenyl 1h pyrazole, 1 (4 aminosulfonylphenyl) 5 hydroxymethyl 3 (2 naphthyl) 1h pyrazole, 1 (4 aminosulfonylphenyl) 5 hydroxymethyl 3 phenyl 1h pyrazole, 4 (5 aryl 2 hydroxymethyl pyrazol 1 yl)benzenesulfonamide, Carbonate dehydratase inhibitor, Carbonic anhydrase, Carbonate dehydratase IX, Carbonate dehydratase ix inhibitor, Doxorubicin, Sulfonamide, Unclassified drug, Antiproliferative activity, Article, Binding kinetics, Cell line, Cell strain MDA MB 231, Drug binding, Drug cytotoxicity, Drug potency, Drug screening, Drug selectivity, Drug structure, Drug synthesis, Enzyme active site, Enzyme inhibition, Hypoxia, Molecular model, Simulation, Antigens, Neoplasm, Binding Sites, Carbonic Anhydrase Inhibitors, Carbonic Anhydrases, Catalytic Domain, Cell Line, Tumor, Cell Proliferation, Pyrazole, Humans, Kinetics, Molecular Docking Simulation, Protein Binding, Pyrazoles, Structure-Activity Relationship, Sulfonamides, 1 (3 aminosulfonylphenyl) 3 hydroxymethyl 5 (6 methoxy 2 naphthalenyl) 1h pyrazole, 1 (3 aminosulfonylphenyl) 3 hydroxymethyl 5 naphthyl 1h pyrazole, 1 (3 aminosulfonylphenyl) 3 hydroxymethyl 5 phenyl 1h pyrazole, info:eu-repo/semantics/article
-
4مورد إلكتروني
مصطلحات الفهرس: Crystal structure, 5-([(4 `-heptoxy-biphenylyl-4-yl)oxy]carbonyl)-l-pentyne(A3E ` O7), TEM, X-ray diffraction, 5-{[(4'-Heptoxy-biphenylyl-4-yl)oxy]carbonyl}-1-pentyne (A3E'O7), 晶體結構, 5-[4′-正庚基-氧-聯苯基-4-氧-羰基]基-1-正戊炔, 透射電鏡, X射線衍射, Article
URL:
http://repository.ust.hk/ir/Record/1783.1-21171Test http://lbdiscover.ust.hk/uresolver?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/HKUST:SPI&rft.genre=article&rft.issn=0251-0790&rft.volume=26&rft.issue=7&rft.date=2005&rft.spage=1366&rft.epage=1368&rft.aulast=Liu&rft.aufirst=LJ&rft.atitle=Crystal+structure+ofTest+5-{[(4+`-heptoxy-biphenylyl-4-yl)oxy]+carbonyl}-1-pentyne http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=LinksAMR&SrcApp=PARTNER_APP&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000230753000045Test http://www.scopus.com/record/display.url?eid=2-s2.0-24744458836&origin=inwardTest -
5مورد إلكتروني
المصدر: Journal of Experimental Medicine
-
6مورد إلكتروني
مصطلحات الفهرس: culture medium, cytokine response, disease predisposition, enzyme linked immunospot assay, ex vivo study, flow cytometry, gene expression, genotype, hematopoietic cell, in vitro study, in vivo study, inflammation, limit of quantitation, lymphocytopenia, mouse, nonhuman, phenotype, 5 chloro n2 [1 (5 fluoro 2 pyrimidinyl)ethyl] n4 (5 methyl 1h pyrazol 3 yl) 2,4 pyrimidinediamine/pd [Pharmacology], APRIL protein/pd [Pharmacology], B cell activating factor/pd [Pharmacology], B lymphocyte induced maturation protein 1/ec [Endogenous Compound], B lymphocyte receptor/ec [Endogenous Compound], Bruton tyrosine kinase/ec [Endogenous Compound], CD40 ligand/pd [Pharmacology], CD45 antigen/ec [Endogenous Compound], CD98 antigen/ec [Endogenous Compound], chemokine receptor CXCR3/ec [Endogenous Compound], chemokine receptor CXCR4/ec [Endogenous Compound], Fas antigen/ec [Endogenous Compound], Fc receptor IIb/ec [Endogenous Compound], Hermes antigen/ec [Endogenous Compound], immunoglobulin E/ec [Endogenous Compound], immunoglobulin G1/ec [Endogenous Compound], interleukin 21/pd [Pharmacology], interleukin 3/pd [Pharmacology], interleukin 4/pd [Pharmacology], interleukin 5/pd [Pharmacology], interleukin 6/pd [Pharmacology], Janus kinase 1/ec [Endogenous Compound], major histocompatibility antigen class 2/ec [Endogenous Compound], myeloid differentiation factor 88/ec [Endogenous Compound], protein kinase Lyn/ec [Endogenous Compound], STAT3 protein/ec [Endogenous Compound], STAT5 protein/ec [Endogenous Compound], tumor necrosis factor/pd [Pharmacology], syndecan 1/ec [Endogenous Compound], plasma cell, plasmacytosis, protein phosphorylation, signal transduction, spleen size, survival factor, Western blotting, 4 amino 7 tert butyl 5 (4 chlorophenyl)pyrazolo[3,4 d]pyrimidine/pd [Pharmacology], 5 chloro n2 [1 (5 fluoro 2 pyrimidinyl)ethyl] n4 (5 methyl 1h pyrazol 3 yl) 2,4 pyrimidinediamine/po [Oral Drug Administration], animal cell, animal experiment, animal model, article, autoimmune disease, B cell culture, B lymphocyte, B lymphocyte differentiation, bone marrow, bone marrow cell, cell count, cell hyperplasia, cell selection, cell surface, cell survival, comparative study, controlled study, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/41761Test
Science Signaling
Click here for full text options
LibKey Link -
7مورد إلكتروني
مصطلحات الفهرس: culture medium, cytokine response, disease predisposition, enzyme linked immunospot assay, ex vivo study, flow cytometry, gene expression, genotype, hematopoietic cell, in vitro study, in vivo study, inflammation, limit of quantitation, lymphocytopenia, mouse, nonhuman, phenotype, 5 chloro n2 [1 (5 fluoro 2 pyrimidinyl)ethyl] n4 (5 methyl 1h pyrazol 3 yl) 2,4 pyrimidinediamine/pd [Pharmacology], APRIL protein/pd [Pharmacology], B cell activating factor/pd [Pharmacology], B lymphocyte induced maturation protein 1/ec [Endogenous Compound], B lymphocyte receptor/ec [Endogenous Compound], Bruton tyrosine kinase/ec [Endogenous Compound], CD40 ligand/pd [Pharmacology], CD45 antigen/ec [Endogenous Compound], CD98 antigen/ec [Endogenous Compound], chemokine receptor CXCR3/ec [Endogenous Compound], chemokine receptor CXCR4/ec [Endogenous Compound], Fas antigen/ec [Endogenous Compound], Fc receptor IIb/ec [Endogenous Compound], Hermes antigen/ec [Endogenous Compound], immunoglobulin E/ec [Endogenous Compound], immunoglobulin G1/ec [Endogenous Compound], interleukin 21/pd [Pharmacology], interleukin 3/pd [Pharmacology], interleukin 4/pd [Pharmacology], interleukin 5/pd [Pharmacology], interleukin 6/pd [Pharmacology], Janus kinase 1/ec [Endogenous Compound], major histocompatibility antigen class 2/ec [Endogenous Compound], myeloid differentiation factor 88/ec [Endogenous Compound], protein kinase Lyn/ec [Endogenous Compound], STAT3 protein/ec [Endogenous Compound], STAT5 protein/ec [Endogenous Compound], tumor necrosis factor/pd [Pharmacology], syndecan 1/ec [Endogenous Compound], plasma cell, plasmacytosis, protein phosphorylation, signal transduction, spleen size, survival factor, Western blotting, 4 amino 7 tert butyl 5 (4 chlorophenyl)pyrazolo[3,4 d]pyrimidine/pd [Pharmacology], 5 chloro n2 [1 (5 fluoro 2 pyrimidinyl)ethyl] n4 (5 methyl 1h pyrazol 3 yl) 2,4 pyrimidinediamine/po [Oral Drug Administration], animal cell, animal experiment, animal model, article, autoimmune disease, B cell culture, B lymphocyte, B lymphocyte differentiation, bone marrow, bone marrow cell, cell count, cell hyperplasia, cell selection, cell surface, cell survival, comparative study, controlled study, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/41761Test
Science Signaling
Click here for full text options
LibKey Link -
8مورد إلكتروني
مصطلحات الفهرس: cerebrovascular disease, patient, coronary artery bypass graft, coronary artery disease, therapy, percutaneous coronary intervention, mortality, register, revascularization, diabetes mellitus, cardiogenic shock, heart infarction, surgery, multivariate analysis, heart ejection fraction, kidney failure, hypertension, peripheral vascular disease, 5 (4 chloro 3 nitrophenyl) 1,4 diphenyl 1,2,4 triazolium 3 thiolate, Conference Abstract
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31149Test
Click here for full text options
LibKey Link -
9مورد إلكتروني
مصطلحات الفهرس: cerebrovascular disease, patient, coronary artery bypass graft, coronary artery disease, therapy, percutaneous coronary intervention, mortality, register, revascularization, diabetes mellitus, cardiogenic shock, heart infarction, surgery, multivariate analysis, heart ejection fraction, kidney failure, hypertension, peripheral vascular disease, 5 (4 chloro 3 nitrophenyl) 1,4 diphenyl 1,2,4 triazolium 3 thiolate, Conference Abstract
-
10مورد إلكتروني
المصدر: Cancer Research
مصطلحات الفهرس: 5 (4 bromo 2 chloroanilino) 4 fluoro 1 methyl 1h benzimidazole 6 carbohydroxamic acid 2 hydroxyethyl ester, article, breast tumor, cancer model, colon, enzyme inhibitor, messenger RNA, mitogen activated protein kinase kinase, phosphatidylinositol 3 kinase, Contribution to Journal
URL: doi:10.1158/0008-5472.CAN-09-1577
Dry, Jonathan, Pavey, Sandra, Pratilas, Christine, Harbron, Chris, Runswick, Sarah, Hodgson, Darren, Chresta, Christine, McCormack, Rose, Byrne, Natalie, Cockerill, Mark, Graham, Alexander, Beran, Garry, Cassidy, Andrew, Haggerty, Carolyn, Brown, Helen, Ellison, Gillian, Dering, Judy, Taylor, Barry, Stark, Mitchell, Bonazzi, Vanessa, Ravishankar, Sugandha, Packer, Leisl, Xing, Feng, Solit, David, Finn, Richard, Rosen, Neal, Hayward, Nicholas, French, Tim, & Smith, Paul (2010) Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244). Cancer Research, 70(6), pp. 2264-2273.